Swiss National Bank’s Atara Biotherapeutics ATRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-6,960
Closed -$505K 2608
2023
Q1
$505K Sell
6,960
-788
-10% -$57.1K ﹤0.01% 2516
2022
Q4
$635K Buy
7,748
+292
+4% +$23.9K ﹤0.01% 2519
2022
Q3
$705K Hold
7,456
﹤0.01% 2466
2022
Q2
$1.45M Buy
7,456
+348
+5% +$67.8K ﹤0.01% 2139
2022
Q1
$1.65M Buy
7,108
+792
+13% +$184K ﹤0.01% 2140
2021
Q4
$2.49M Hold
6,316
﹤0.01% 1911
2021
Q3
$2.83M Buy
6,316
+48
+0.8% +$21.5K ﹤0.01% 1827
2021
Q2
$2.44M Sell
6,268
-476
-7% -$185K ﹤0.01% 1975
2021
Q1
$2.42M Buy
6,744
+360
+6% +$129K ﹤0.01% 1897
2020
Q4
$3.13M Buy
6,384
+220
+4% +$108K ﹤0.01% 1652
2020
Q3
$2M Buy
6,164
+92
+2% +$29.8K ﹤0.01% 1719
2020
Q2
$2.21M Buy
6,072
+2,292
+61% +$835K ﹤0.01% 1658
2020
Q1
$804K Buy
3,780
+80
+2% +$17K ﹤0.01% 1954
2019
Q4
$1.52M Buy
3,700
+144
+4% +$59.3K ﹤0.01% 1884
2019
Q3
$1.26M Buy
3,556
+464
+15% +$164K ﹤0.01% 1938
2019
Q2
$1.56M Buy
3,092
+760
+33% +$382K ﹤0.01% 1852
2019
Q1
$2.32M Buy
2,332
+88
+4% +$87.4K ﹤0.01% 1578
2018
Q4
$1.95M Buy
2,244
+140
+7% +$122K ﹤0.01% 1592
2018
Q3
$2.18M Hold
2,104
﹤0.01% 1663
2018
Q2
$1.93M Hold
2,104
﹤0.01% 1735
2018
Q1
$2.05M Buy
2,104
+960
+84% +$936K ﹤0.01% 1622
2017
Q4
$518K Hold
1,144
﹤0.01% 2400
2017
Q3
$473K Hold
1,144
﹤0.01% 2395
2017
Q2
$400K Hold
1,144
﹤0.01% 2466
2017
Q1
$588K Buy
1,144
+100
+10% +$51.4K ﹤0.01% 2313
2016
Q4
$371K Hold
1,044
﹤0.01% 2482
2016
Q3
$558K Hold
1,044
﹤0.01% 2309
2016
Q2
$588K Hold
1,044
﹤0.01% 2263
2016
Q1
$479K Buy
1,044
+208
+25% +$95.4K ﹤0.01% 2325
2015
Q4
$552K Hold
836
﹤0.01% 2202
2015
Q3
$657K Buy
836
+276
+49% +$217K ﹤0.01% 2029
2015
Q2
$739K Buy
+560
New +$739K ﹤0.01% 1993